Back to the main directory
Press Release
- Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice by GlobeNewsWire
- Romios Announces Closing of First Tranche of Non-Brokered Offering for $85,000 by Newsfile Corp.
- Q&A on Arbuthnot Banking Group (ARBB): 1H’24 results - multiple options to get the most from the franchise by EQS Group AG
- Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer by GlobeNewsWire
- Sportradar to Participate in Canaccord Genuity 44th Annual Growth Conference by GlobeNewsWire
- KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update by GlobeNewsWire
- Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference by GlobeNewsWire
- aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations by GlobeNewsWire
- Plains All American Releases 2023 Sustainability Report by GlobeNewsWire
- iLearningEngines Addresses Data Security Approach for AI Development, Deployment by GlobeNewsWire
- Twin Disc Approves a Quarterly Cash Dividend by GlobeNewsWire
- Where Food Comes From, Inc. Schedules 2024 Second Quarter Earnings Call by GlobeNewsWire
- Super League and Meta-Stadiums Partner to Expand Cross-Platform Immersive Experiences with End-to-End Metaverse Marketing Strategies for Global Brands by GlobeNewsWire
- Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update by GlobeNewsWire
- Rocky Mountain Chocolate Factory Announces $2.2 Million Private Placement by GlobeNewsWire
- New Research Predicts an Increase in Allocation from Institutional and Retail Investors to Small- and Micro-Caps Over the Next 12 Months by GlobeNewsWire
- Portillo’s Inc. Announces Second Quarter 2024 Financial Results by GlobeNewsWire
- Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan by GlobeNewsWire
- Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference by GlobeNewsWire
- Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer by GlobeNewsWire
- Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS by GlobeNewsWire
- Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country by GlobeNewsWire
- Burcon Announces Fiscal 2025 First Quarter Conference Call to be Held on August 14, 2024 by Newsfile Corp.
- Edizione 77, Locarno Film Festival 2024 Sotto i riflettori: Pardo d'onore Manor, Pardo Boutique by Manor e un'esperienza esclusiva per i clienti myManor by EQS Group AG
- Édition 77, Locarno Film Festival 2024 Sous les projecteurs : Pardo d'onore Manor, Pardo Boutique by Manor et expérience exclusive pour les clientes et clients myManor by EQS Group AG
- Cosa Resources Completes the Expansion of its 100% Owned Orbit Uranium Project, Athabasca Basin, Saskatchewan by Newsfile Corp.
- Danske Bank A/S, transactions by persons discharging managerial responsibilities by GlobeNewsWire
- Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024 by GlobeNewsWire
- Great Lakes Reports Second Quarter 2024 Results by GlobeNewsWire
- iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024 by GlobeNewsWire
- Reviva Announces Grant of U.S. Patent Covering Use of Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis by GlobeNewsWire
- Nearly Six out of 10 Consumers Betting $500 or More Per Month Online Are Millennials by GlobeNewsWire
- Core Molding Technologies Reports Fiscal 2024 Second Quarter Results by GlobeNewsWire
- Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens by GlobeNewsWire
- Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist by GlobeNewsWire
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC by GlobeNewsWire
- Advantage Solutions Receives Amazon’s Inaugural Gold Tier Award, Reflecting Excellence in Omnicommerce Performance by GlobeNewsWire
- Talkspace Announces Second Quarter 2024 Results by GlobeNewsWire
- Celestica Announces Availability of the SC6100: A Next-Generation Storage Controller for Demanding Enterprise Workloads by GlobeNewsWire
- L.B. Foster Company Reports Tempered Second Quarter Results after Strong First Quarter; Updates 2024 Financial Guidance and Stock Repurchase Program; Continues Enterprise Restructuring Aligned with Growth Strategy by GlobeNewsWire
- Mullen CEO Provides Company Update by GlobeNewsWire
- Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results by GlobeNewsWire
- Xunlei Limited Schedules 2024 Unaudited Second Quarter Earnings Release on August 13, 2024 by GlobeNewsWire
- MAX Power Nearly Triples Size of Rider Natural Hydrogen Project, Stakes 2,112 Additional Sq. Km by GlobeNewsWire
- 87% of Early Proxies Favor CareCloud’s Series A Proxy Proposal by GlobeNewsWire
- TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection by GlobeNewsWire
- Seanergy Maritime Reports Record Second Quarter and First Half Financial Results for the Periods Ended June 30, 2024 by GlobeNewsWire
- MARA Announces Bitcoin Production and Mining Operation Updates for July 2024 by GlobeNewsWire
- Ausgabe 77, Locarno Film Festival 2024 Im Scheinwerferlicht: Pardo d’onore Manor, Pardo Boutique by Manor und exklusives Erlebnis für myManor Kund*innen by EQS Group AG
- Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder by BusinessWire